SCHEMBL7998477

SCHEMBL7998477

CCCCCCCCCC#COC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN7 P35236 5/20 0.43
HMGCR P04035 3/20 0.43
TSHR P16473 1/20 0.40
THRB P10828 1/20 0.40
RECQL P46063 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
KCNH2 Q12809 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
ALOX12 P18054 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
MCL1 Q07820 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
EPHX2 P34913 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28783031 1.00 PTPN7 (0.43) PTPN7HMGCRTSHRTHRBRECQL
SCHEMBL5168905 1.00 PTPN7 (0.43) PTPN7HMGCRTSHRTHRBRECQL
SCHEMBL7998451 1.00 PTPN7 (0.43) PTPN7HMGCRTSHRTHRBRECQL
SCHEMBL5169819 1.00 PTPN7 (0.43) PTPN7HMGCRTSHRTHRBRECQL
SCHEMBL5169816 1.00 PTPN7 (0.43) PTPN7HMGCRTSHRTHRBRECQL
SCHEMBL10632895 1.00 PTPN7 (0.43) PTPN7HMGCRTSHRTHRBRECQL
SCHEMBL7987835 1.00 PTPN7 (0.43) PTPN7HMGCRTSHRTHRBRECQL
SCHEMBL5170452 1.00 PTPN7 (0.43) PTPN7HMGCRTSHRTHRBRECQL
SCHEMBL5168889 1.00 PTPN7 (0.43) PTPN7HMGCRTSHRTHRBRECQL
SCHEMBL5170466 1.00 PTPN7 (0.43) PTPN7HMGCRTSHRTHRBRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10731159-B2 Cationic lipid DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-08-04 US disclosed
US-20200080086-A1 CATIONIC LIPID DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-03-12 US disclosed
EP-3020701-B1 NOVEL LIPID DAIICHI SANKYO CO LTD (JP) 2018-09-26 EP disclosed
US-20180051285-A1 CATIONIC LIPID DAIICHI SANKYO COMPANY, LIMITED (JP) 2018-02-22 US disclosed
US-9803199-B2 Cationic lipid DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-10-31 US disclosed
US-20160257951-A1 NOVEL LIPID DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-09-08 US disclosed
EP-3020701-A1 NOVEL LIPID DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-05-18 EP disclosed
US-6288038-B1 ACCELERATE APOLIPOPROTEIN E PRODUCTION; NERVOUS SYSTEM DISORDERS, ALZHEIMER*S DISEASE; ANTILIPEMIC AGENTS NISSHIN SEIFUN GROUP INC. (JP) 2001-09-11 US disclosed
EP-1028126-A1 DEPSIPEPTIDE DERIVATIVES BEARING PIPERAZINONE RINGS Nisshin Flour Milling Co., Ltd. (JP) 2000-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160257951-A1 NOVEL LIPID NPC1L1, CETP, LIPC PTPN7 3976/4885HMGCR 292/4885TSHR 4094/4885
US-20180051285-A1 CATIONIC LIPID CETP, NPC1L1, LIPA PTPN7 3962/4885HMGCR 511/4885TSHR 3456/4885
US-20200080086-A1 CATIONIC LIPID CETP, NPC1L1, LIPA PTPN7 3962/4885HMGCR 511/4885TSHR 3456/4885
US-10731159-B2 Cationic lipid CETP, NPC1L1, LIPA PTPN7 3962/4885HMGCR 511/4885TSHR 3456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.